- Home
- DXST vs LSTA Comparison
DXST vs LSTA Comparison
Compare DXST & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXST
- LSTA
- Stock Information
- Founded
- DXST 2011
- LSTA 1980
- Country
- DXST China
- LSTA United States
- Employees
- DXST N/A
- LSTA N/A
- Industry
- DXST
- LSTA Misc Health and Biotechnology Services
- Sector
- DXST
- LSTA Health Care
- Exchange
- DXST NYSE
- LSTA Nasdaq
- Market Cap
- DXST 20.3M
- LSTA 20.0M
- IPO Year
- DXST 2025
- LSTA N/A
- Fundamental
- Price
- DXST $1.33
- LSTA $2.07
- Analyst Decision
- DXST
- LSTA Strong Buy
- Analyst Count
- DXST 0
- LSTA 1
- Target Price
- DXST N/A
- LSTA $15.00
- AVG Volume (30 Days)
- DXST 54.3K
- LSTA 9.1K
- Earning Date
- DXST 01-01-0001
- LSTA 05-08-2025
- Dividend Yield
- DXST N/A
- LSTA N/A
- EPS Growth
- DXST 13.11
- LSTA N/A
- EPS
- DXST 0.14
- LSTA N/A
- Revenue
- DXST $11,542,292.00
- LSTA $1,000,000.00
- Revenue This Year
- DXST N/A
- LSTA N/A
- Revenue Next Year
- DXST N/A
- LSTA N/A
- P/E Ratio
- DXST $8.91
- LSTA N/A
- Revenue Growth
- DXST 22.18
- LSTA N/A
- 52 Week Low
- DXST $0.86
- LSTA $2.05
- 52 Week High
- DXST $5.74
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- DXST N/A
- LSTA 34.86
- Support Level
- DXST N/A
- LSTA $2.31
- Resistance Level
- DXST N/A
- LSTA $2.46
- Average True Range (ATR)
- DXST 0.00
- LSTA 0.15
- MACD
- DXST 0.00
- LSTA -0.01
- Stochastic Oscillator
- DXST 0.00
- LSTA 0.00
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.